PROGRAM
The committee is excited to announce the program is now available. This will continue to be updated as details are confirmed, please note this is subject to change without notice.
For details on how to claim points for Continuing Professional Development (CPD) for attendance at the Virtual APSAD 2021 Conference, click here.
Click on the tabs below to view the program for each day. All times are in Australian Eastern Standard Time (AEST) unless stated otherwise.
09:00 – 17:00
The annual Australasian Smoking Cessation Professionals (ASCP) Update Day
9:00am – 12:00pm (AEST)
Fetal Alcohol Spectrum Disorder Special Interest Group (FASD-SIG)
9:00am – 5:00pm (AEST)
09:00 – 10:15
Opening Plenary Session
Welcome to Country
Welcome to the 40th APSAD Conference
Conference Opening Address
INVITED SPEAKER: Exploring the impact of FASD among Aboriginal and Torres Strait Islander children and youth and considering their needs
Sharynne Hamilton, Post-Doctoral Research Fellow, Aboriginal Health with the Telethon Kids Institute, WA
Poster Highlights Session 1
#198 Cannabis-induced dysphoria/paranoia mediates the link between childhood trauma and psychotic-like experiences in young cannabis users
Molly Carlyle, Llw Postdoctoral Research Fellow, University Of Queensland, QLD
#152 Evidence that the Northern Territory’s minimum price targets heavy alcohol consumption
Nicholas Taylor, PhD Candidate,
Deakin University, VIC
#327 Development of a culturally appropriate, national website about crystal methamphetamine
Steph Kershaw, Postdoctoral Research Fellow,
University of Sydney, NSW
#72 Impact of adolescent methamphetamine use on social cognition
Lauren Hanegraaf, PhD Candidate,
Monash University, VIC
10:30 – 11:00
Morning Tea Break
11:00 – 12:15
Concurrent Session 1A
First Nations
Concurrent Session 1B
Tobacco Control
Chair: Coral Gartner
Concurrent Session 1C
Decriminalisation
Special Populations
Concurrent Session 1D
FASD
Parental Supply
#7 Young Aboriginal people who have never used marijuana in the ‘Next Generation Youth Well-being study’: a strengths-based approach
Simon Graham, Senior Research Fellow,
Peter Doherty Institute For Infection And Immunity, VIC
#265 Weaving Indigenous and Western worldviews within neuropsychological assessment for Fetal alcohol spectrum disorder
Sarah Goldsbury, Clinical Neuropsychologist
Māori/Indigenous Health Institute, University of Otago Christchurch, New Zealand
#316 Overcoming Aboriginal alcohol harm in Australia: Building on the evidence
Peter Dabbs, Honorary Fellow,
Menzies School Of Health Research, NT
#285 Supporting Aboriginal Community Controlled Health Services in alcohol screening and care
Scott Wilson, National Drug Research
Institute, Curtin University, WA & Kate Conigrave, Senior Staff Specialist,
Royal Prince Alfred Hospital, NSW
Gary Chan, Senior Research Fellow,
Ncysur, QLD; Tianze Sun, Ncysur, QLD; Carmen Lim, Ncysur, QLD; & Kylie Morphett, School of Public Health, The University of Queensland, QLD
Mini Workshop 1
#259 Language Matters and it starts with us: Alcohol & other drugs and decriminalisation
Alice Salomon, Social Justice Lead,
Uniting, NSW
#140 Fatal and nonfatal overdose after release from prison: Findings from data linkage studies in Australia and Canada
Stuart Kinner, Head, Justice Health Unit,
University Of Melbourne & Murdoch Children’s Research Institute, VIC
#111 Retention in primary care-based opioid agonist treatment is associated with reduced ambulance and emergency department contact following release from prison
Michael Curtis, PhD Candidate,
Burnet Institute, VIC
#104 Adverse Childhood Experiences and Associated Stressors in Young People with Fetal Alcohol Spectrum Disorder Across the Justice and Child Protection Settings in Western Australia
Grace Kuen Yee Tan, Provisional Psychologist,
University Of Western Australia, WA
#40 Evidence-Based Online Training and Support Courses for Caregivers of Youth with FASD
Anita Gibbs, School of Social Sciences, University of Otago, Dunedin, New Zealand & Julie Flanagan, National Projects & Communications Manager,
NOFASD, Australia
#148 Are Australian teens with parental permission to drink at home engaging in riskier alcohol use behaviours? Results from a national sample
Brendan Quinn, Research Fellow,
Australian Institute Of Family Studies, VIC
#10 Exposure to parental alcohol use is associated with adolescent drinking even when accounting for best friend’s and peers’ exposure – Results from a longitudinal multilevel study
Emmanuel Kuntsche, Director,
Centre For Alcohol Policy Research (CAPR), La Trobe University, VIC
#273 Trajectories of parental and peer supply of alcohol across adolescence and associations with later alcohol drinking and harms: A prospective cohort study
Alexandra Aiken, Senior Research Officer,
National Drug And Alcohol Research Centre, NSW
12:20 – 12:50
Lunch Break
12:55 – 15:00
Afternoon Plenary – Invited Speakers, Poster Highlights & APSAD Awards
INVITED SPEAKER: Presentation Title TBC
Chris Gough, Secretary, Australian Illicit and Injecting Drug Users League (AIVL), Australia
Poster Highlights Session 2
#235 The impact of the COVID-19 pandemic on AOD staff, clients, and services
Grace Newland, Clinical Masters Student & Research Tech, University Of Queensland, QLD
#216 The Counselling Online forum: Innovative approaches to build peer support and online connection for people living with addiction
Annette Peart, Research Fellow,
Monash University, VIC
#31 Identifying perceived barriers and facilitators to accessing effective clinical supervision and the implementation of a clinical supervision exchange model in the alcohol and other drug sector
Courtney O’Donnell, Sector And Workforce Development Officer, QNADA, QLD
#3 The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: A 15-year retrospective cohort study
Chrianna Bharat, PhD Candidate,
National Drug & Alcohol Research Centre, NSW
#185 Joint trajectories of heroin use and treatment utilisation over 10-years
Christina Marel, Senior Research Fellow,
The University Of Sydney, NSW
#187 Improving assessment and management of suicide risk at the Uniting Medically Supervised Injecting Centre (MSIC), Sydney
Kate Hocknull, Mental Health Nurse Coordinator; Clinical Nurse Consultant,
United MSIC, NSW
#86 A novel responsive telehealth intervention to address overdose risk for people recently released from prison – the ROADS (Released Offender Alcohol and Drug Support) project
Heidi Deifel-carlino, Senior Counsellor And Trainer,
Adis 24/7 Alcohol & Drug Support, QLD
#78 Does Housing Context Influence Social Identity Transition and Outcomes of Therapeutic Community Treatment?
Genevieve Dingle, Associate Professor In Clinical Psychology,
University of QLD, QLD
#143 Pilot feasibility trial of Cognitive Processing Therapy for young people with comorbid Posttraumatic Stress and Substance Use Disorders in residential substance use treatment
Valeriya Mefodeva, PhD Student,
University of Queensland, QLD
#295 “I wouldn’t know what to do if they cut me off”: Unique barriers to help seeking in consumers with pharmaceutical opioid dependence
Carina Walters, Doctoral Candidate,
University of Auckland, New Zealand
INVITED SPEAKER: Parenting, emotional regulation and substance use: investigating the process of change
Sharon Dawe, Professor in Clinical Psychology, Griffith University, Australia
APSAD Awards Presentation: First Peoples & Senior Scientist
INVITED SPEAKER: The challenges ahead for psychedelic medicines
Suresh Muthukumaraswamy, University of Auckland, School of Pharmacy, New Zealand
15:00 – 15:30
Afternoon Tea Break
15:30 – 16:45
Concurrent Session 2A
Peers & Perspectives
Chair: Sione Crawford
Concurrent Session 2B
Long Acting Injectable Buprenorphine
Chair: Mark Daglish
Concurrent Session 2C
Youth
Chair: Genevieve Dingle
Concurrent Session 2D
Workforce & Treatment Settings
Chair: Anke van der Sterren
Mini Symposium
#305 Interventions to Improve Access to Hepatitis C Testing and Treatment for People Who Use Drugs
Evan Cunningham, Mark Montebello & Esha Leyden
#76 Partnering peer specialists with nurses to expand access to hepatitis C care for people who inject drugs: The path-expanded model evaluation
Daniel O’Keefe, Senior Research Officer,
Burnet Institute, VIC
#158 Insights from the Public Participation Review
Gregory Taylor, Lived Experience Participation Officer,
Alcohol, Tobacco And Other Drugs Council Of Tasmania, TAS
#182 “We’ve had a circuit breaker for an old dogma of more than 20 years”: Changes to opioid agonist treatment services during COVID-19, the CHOICE study
Anna Conway, PhD Student,
Kirby Institute, University of New South Wales, NSW
Q&A
Symposium 2
#232 An overview of Australian clinical research trials of depot (long-acting) buprenorphine
Nicholas Lintzeris, Director, Drug And Alcohol Services,
South East Sydney Local Health District, NSW; Michael Farrell, National Drug and Alcohol Research Centre, University of New South Wales Sydney, Sydney, NSW; & Adrian Dunlop, Hunter New England Local Health District, Newcastle, NSW
Discussant: Paul Haber, Professor , Sydney Local Health District, NSW
#33 Substances and senses: Exploration of the sensory patterns of young people within an alcohol and drug treatment service
John Kelly, Team Leader / Psychologist,
Metro North Mental Health – Alcohol And Drug Service, QLD & Michelle Taylor, Insight: Centre for alcohol and other drug training and workforce development,
Metro North Mental Health – Alcohol and Drug Service, QLD
#276 Student Perceptions of the Drinking Culture in Three Queensland Residential Colleges: Causes, Consequences & Recommendations
Lily Davidson, PhD student,
University of Queensland, QLD
#82 Characteristics of Young People at Index Alcohol-related Hospital Admissions and Emergency Department Presentations in Australia: a retrospective data linkage cohort
Wing See Yuen, Research Officer,
NDARC, NSW
#164 A combined Web Based and Ecological Momentary Intervention for incoming first-year university students: A three-arm randomised controlled trial
Benjamin Riordan, Post Doctoral Research Fellow,
La Trobe University, VIC
Rapid Fire Presentations
#126 How cannabis use is portrayed to adolescents and young adults via TikTok: A thematic content analysis
Brienna Rutherford, PhD Candidate,
National Centre For Youth Substance Use Research, QLD
#11 Alcohol and recreational drug use in young adults with type 1 diabetes – doing harm reduction in people with medical comorbidities
Adam Pastor, Addiction Medicine Specialist,
St Vincent’s Hospital Melbourne, VIC
#161 Tracking the decline in adolescent drinking into adulthood, an Australian analysis
Michael Livingston, Associate Professor,
National Drug Research Institute, Curtin University, WA
Q&A
#16 Exploring lived experience in the alcohol and other drugs workforce
Victoria Kostadinov, Senior Research Officer,
National Centre For Education And Training On Addiction, Australia & Natalie Skinner, Senior Research Fellow, Flinders University NCETA, SA
#142 Wellbeing at work: Exploring burnout & engagement in early and mid/late career alcohol and other drugs workers
Natalie Skinner, Senior Research Fellow, Flinders University NCETA, SA
#18 The association between treatment commissioning mechanisms and ensuing workforce characteristics, and alcohol and other drug treatment outcomes
Alison Ritter, Director, DPMP
University of New South Wales Sydney, NSW
#13 “We have to accept that not everybody’s gonna have an abstinence outcome”: Exploring the views of funders, treatment providers and service users on performance measurement
Robert Stirling, CEO,
Network Of Alcohol And Other Drug Agencies, NSW
#302 Tracing scientific and social understandings of alcohol and other drug problems over thirty-one scientific sessions of the Australian Summer School of Studies on Alcohol (1966-1997)
Claire Wilkinson, Research Fellow,
The University Of New South Wales, NSW
Q&A
09:00 – 10:25
Morning Plenary – Invited Speakers & APSAD Awards
Chair: Michael Farrell
INVITED SPEAKER: Sitting with Distress: Mechanisms of Mindfulness-Based Interventions in the Treatment of Substance Use Disorders
Katie Witkiewitz, Regents’ Professor of Psychology and scientist, Center on Alcohol, Substance use, And Addictions at the University of New Mexico, United States
APSAD Awards Presentation: Clinician, Advocacy & Mentor
INVITED SPEAKER/JAMES RANKIN ORATION: The Research-Policy-Practice Interfaces in the Alcohol & Other Drugs Field, Past, Present & Future
David McDonald
10:25 – 10:50
Morning Tea Break
10:50 – 12:05
Concurrent Session 3A
COVID-19
Chair: Michael White
Concurrent Session 3B
Alcohol
Chair: Caroline Salom
Concurrent Session 3C
Treatment Settings
Chair: Robert Stirling
Concurrent Session 3D
Women’s Issues
#80 Longitudinal Study of the Impact of COVID-19 on Stress, Loneliness, and Risky Drinking in University Students
Genevieve Dingle, Associate Professor In Clinical Psychology, University of Queensland, QLD
#165 Changes in alcohol use and mental health among young Australian adults during the COVID-19 pandemic: A prospective cohort study
Philip Clare, Biostatistician
Prevention Research Collaboration, University of Sydney, NSW
#258 A cross-sectional and longitudinal analysis of substance use behaviours and emotional wellbeing in Australian senior high school students living through the COVID-19 pandemic
Rhiannon Ellem, Research Technician
University Of Queensland, QLD
#157 COVID-19 vaccine hesitancy among Australians who use drugs
Olivia Price, Research Officer
National Drug And Alcohol Research Centre, NSW
#22 Impact and implications: the COVID-19 pandemic and the non-government alcohol and other drug sector
Robert Stirling, CEO,
Network Of Alcohol And Other Drug Agencies, NSW
Q&A
#202 Ready2Change: A randomised controlled trial of a telephone-delivered intervention for problem alcohol use
Dan Lubman, Executive Clinical Director,
Turning Point, VIC
#132 The Geography of Sobriety Checkpoints and Alcohol-Impaired Driving in Queensland
Christopher Morrison, Assistant Professor,
Columbia University, United States
#65 The relationship between alcohol use and dementia: A combined analysis of prospective, individual-participant data from 15 international studies
Rachel Visontay, Research Assistant,
The University Of New South Wales, NSW
#8 A historical overview of alcohol-focused legislative interventions in the Northern Territory of Australia: 1979-2020
Sarah Clifford, Research Assistant / PhD Student,
Menzies School of Health Research, NT
Food For Thought – Alcohol
#250 Drink and drug driving education in the Northern Territory: A qualitative study illustrating issues of access and inequities
Cassandra Wright, Research Fellow,
Menzies School Of Health Research, NT
#39 A Model of Cognitive Assessment in Community Drug and Alcohol Services: Why, What, and How?
Nicole Ridley, Clinical Neuropsychologist,
SESLHD Drug & Alcohol Service, NSW & Jody Kamminga, Drug and Alcohol Services, Hunter New England Local Health District, NSW
#67 A Citizens’ Wānanga on alcohol policy in Aotearoa New Zealand (VIRTUAL)
Oliver Sutcliffe, Student,
Otago Medical School, New Zealand
Q&A
Suzie Hudson, Clinical Director
NADA, NSW; Robert Stirling, NADA, NSW; Leanne Hides, National Centre for Youth Substance Use Research, School of Psychology, The University of Queensland, QLD; Holly Stokes, Nicholas Lintzeris, Sydney School of Medicine, The University of Sydney, NSW; Michael Farrell, National Drug and Alcohol Research Centre (NDARC) University of New South Wales, NSW; Holly Stokes, Research and Outcomes Coordinator, Lives Lived Well, QLD
Late Breaking Session 1: FASD
#335 Sex- and tissue- specific effects of binge levels of prenatal alcohol consumption on DNA methylation at birth: a potential link with FASD
Yuk Jing (Jane) Loke, Research Coordinator,
MCRI, VIC
#323 Fetal Alcohol Spectrum Disorder: Taking Back our Narrative
Robyn Williams, Senior Research Fellow, Curtin University, WA and Nicole Hewlett, Researcher, University of Queensland, QLD
#348 Where pregnant women obtain information about alcohol use in pregnancy
Tracey Tsang, Senior Research Fellow,
The University Of Sydney, NSW
Q&A
#227 A pre-implementation study to understand women’s knowledge of the alcohol-breast cancer link, and acceptability of alcohol brief intervention in the breast screen setting
Jasmin Grigg, Research Fellow,
Turning Point, VIC
#220 A qualitative description of smoking, stigma and culture among pregnant women with substance use problems in Australia
Melissa Jackson, Clinical Research Coordinator,
Hunter New England LHD Drug and Alcohol Clinical Services, NSW
#49 Practice change intervention to improve antenatal care for alcohol consumption: a randomised stepped wedge controlled trial
Emma Doherty, Project Officer,
Hunter New England Local Health District, NSW
#17 Exploring women’s alcohol consumption through a work-family lens
Victoria Kostadinov, Senior Research Officer,
National Centre For Education And Training On Addiction, SA
Food For Thought
#122 – Healthy Filming Project: Improving ability to manage impacts of substance use through storytelling and film-making among culturally and linguistically diverse communities
Neeloy Alam, Research and Project Manager,
Drug and Alcohol Multicultural Education Centre, NSW
#123 Are we getting better at providing culturally responsive alcohol and other drug treatment in Australia?
Yasmin Iese, Drug and Alcohol Multicultural Education Centre, NSW
#261 The experience of being release from jail: A case study
Daisy Gibbs, Research Officer/PhD Candidate,
National Drug And Alcohol Research Centre, University Of New South Wales, NSW
Q&A
12:05 – 12:50
On Demand & e-Poster Session
12:10 – 13:10
Sponsor Educational Symposium – Camurus
12:50 – 13:20
Lunch Break
15:20 – 16:35
Concurrent Session 4A
Festivals
Concurrent Session 4B
Trauma Informed Care
Chair: Leanne Hides
Concurrent Session 4C
Consumer Perspectives: Opioid Agonist Therapy
Chair: Charles Henderson
Concurrent Session 4D
Tobacco Cessation
#224 Responding to drug policing at the festival gates: Implications for the utility of drug amnesty bins
Jodie Grigg, Research Associate,
National Drug Research Institute, Curtin University, WA
#30 Correlates of higher risk drug related behaviours at music festivals in New South Wales, Australia
Amy Healey, Student,
The University Of New South Wales – Medicine, NSW
#238 Fourier Transform Infrared Spectroscopy vs The Lab: An assessment of FTIR as an independent testing technique for drugs seized in Queensland
Karen Blakey, Senior Chemist, Illicit Drug Group, Forensic Chemistry Queensland Health Forensic and Scientific Services, QLD
#352 Using triangulated survey and wastewater data to understand patterns of illicit drug use among Australian music festival attendees
Cheneal Puljevic, Research Fellow,
The University Of Queensland, QLD
#64 Changing trends in attitudes toward cannabis and frequent cannabis use in Australia: The effects of age, period and birth cohort
Vivian Chiu, PhD Candidate
NCYSUR, QLD
Q&A
Symposium 5
#218 Integrating trauma-informed care into substance use treatment
Valeriya Mefodeva, School of Psychology, The University of Queensland, QLD; Petra Staiger, School of Psychology, Deakin University, VIC; Molly Carlyle, Llw Postdoctoral Research Fellow, University Of Queensland, QLD; & Katherine Mills, The Matilda Centre for
Research in Mental Health and Substance Use, The University of Sydney, NSW
Discussant: James Curtain, Director – Clinical services & Clinical Integrity, Lives Lived Well, QLD
#5 Exposure to childhood trauma and opioid use disorder among people prescribed opioids for chronic pain: a latent class and discrete-time analysis
Thomas Santo Jr, Mres Candidate & Research Officer,
National Drug & Alcohol Research Centre, University of New South Wales Sydney, NSW
Symposium 3
#300 Consumer Experiences of Long-Acting Injectable Buprenorphine
Kari Lancaster, Centre for Social Research in Health, University of New South Wales, NSW; Anthony Barnett, Monash Addiction Research Centre, Eastern Health Clinical School, Monash University,
VIC; Bethany White, Sydney School of Medicine (Central Clinical School), The University of Sydney, NSW; Leah Mcleod, NSW Users and AIDS Association, NSW; & Sarah Lord, Harm Reduction Victoria, VIC
Rapid Fire Presentations
Chair: Victoria Hayes
#366 Transferring from methadone to depot buprenorphine formulations
Nicholas Lintzeris, Director, Drug And Alcohol Services
South East Sydney Local Health District, NSW
#367 Experiences and outcomes of depot buprenorphine treatment in clients with concurrent opioid dependence & chronic pain
Apo Demirkol, Drug & Alcohol Services, South East Sydney Local Health District, NSW
#368 Depot buprenorphine treatment in pregnancy
Marcia Sequeira, Hunter New England Local Health District, NSW & Hester Wilson, Drug & Alcohol Clinical Research & Improvement Network, NSW Health, NSW
Q&A
#89 Adherence of nicotine containing e-fluids available to Australian consumers to the new TGA standard for vaporiser nicotine
Jody Morgan, Lecturer, University Of Wollongong, NSW
#59 The comparative cardiovascular safety of smoking cessation pharmacotherapies
Alys Havard, Senior Research Fellow,
National Drug And Alcohol Research Centre, NSW
#57 Barriers in managing tobacco dependence in under 18s’: highlights from interviews with clinicians in Queensland
Rebecca Mounsey, Senior Social Worker,
Dovetail, QLD
#96 Engaging Aboriginal and Torres Strait Islander Queenslanders in a telephone-based intensive quit support program
Joanne Isbel, Health Contact Centre, Queensland Ambulance Service, Department of Health, QLD
Q&A
Rapid Fire Presentations
#154 A co-design project to raise awareness of the harms of shisha smoking among young people
Lilian Chan, PhD Candidate,
University Of Sydney, NSW
#214 Prioritising Populations to Increase Smoking Cessation: Targeted Nicotine Dependence Treatment within Alcohol & Other Drug Services
Anke Van Der Sterren, Senior Researcher And Project Manager, Alcohol Tobacco And Other Drug Association, ACT
Discussion
14:35 – 15:05
Afternoon Tea Break
15:05 – 16:50
Afternoon Plenary – Invited Speakers & Late Breaking Session
INVITED SPEAKER: Investing in families for societies resilient to drugs and crime – the role of effective drug prevention, treatment and care
Anje Busse
INVITED SPEAKER: Can we use psychedelics and MDMA to disrupt the brain processes of addiction?
David Nutt
Late Breaking Session: NPS / Testing session / MSIR
#380 Health Outreach: A model of providing harm reduction services and healthcare to the homeless in temporary accommodation
Nicolas Clark, Medical Director,
North Richmond Community Health, VIC
#339 Early findings from novel methods of surveillance for novel synthetic opioids and other psychoactive substances within Supervised Injecting Facilities
Suzanne Nielsen, Deputy Director,
Monash Addiction Research Centre, Monash University, VIC
#350 Illicit drug use and overdose outcomes at MSIR during Melbourne’s COVID19 lockdown: results from the RAPID early warning system
Nicolas Clark, Medical Director,
North Richmond Community Health, VIC
#379 Profile and correlates of colorimetric reagent kit use among people who use ecstasy/MDMA and other illegal stimulants in Australia, 2019-2021
Daisy Gibbs, Research Officer/PhD Candidate,
National Drug And Alcohol Research Centre, University Of New South Wales, NSW
#336 Comparing medication-related risk using prescription drug monitoring program algorithms and the ROOM clinical screening tool
Louisa Picco, PhD Candidate,
Monash University, VIC
Q&A
09:00 – 10:15
Concurrent Session 5A
Community Treatment & Residential Rehab
Chair: Briony Larance
Concurrent Session 5B
Take Home Naloxone
Chair: Caroline Salom
Concurrent Session 5C
Treatment
Concurrent Session 5D
Tobacco Use in Pregnancy
Chair: Gillian Gould
#372 Opportunities to address smoking in residential alcohol and other drug treatment
Peter J. Kelly, Associate Professor,
University Of Wollongong, NSW
#373 Alcohol and other drugs characteristics amongst people with mental ill-health participating in a smoking cessation trial
Kristen McCarter, Postdoctoral Researcher,
University Of Newcastle, NSW
#354 Controlled trial examining the strength-based Grit Wellbeing and Self-regulation Program for young people in residential settings for substance use
Zoe Walter, Lecturer,
University Of Queensland, QLD
#112 Hospitalisation following residential drug and alcohol treatment for young people with and without a history of criminal conviction
Tyson Whitten, Lecturer,
University Of Adelaide, SA
#355 Six-month outcomes from an randomised control trial of a continuing care telephone intervention following residential substance dependence treatment
Peter J. Kelly, Associate Professor,
University Of Wollongong, NSW
Q&A
Symposium 6
#304 Take Home Naloxone: Recent achievements and new pathways towards universal access
Angela Matheson, Centre for Alcohol & Other Drugs, NSW
Ministry of Health, NSW; Tegan Nuckey, QuIHN, QLD; Robyn Greaves, Policy and Project Officer,
Tasmanian Department of Health, TAS; Grace Oh, Mental Health Commission, WA; Suzanne Nielsen, Behaviours and Health Risks, Burnet Institute, VIC
Discussant: Paul Dietze, Burnet Institute, VIC
#200 Hypothalamic-pituitary-adrenocortical response in alcohol patients during baclofen treatment and association with clinical outcome
Kirsten Morley, Principal Research Fellow,
Sydney University, NSW
#360 Reducing relapse in severe alcohol use disorder with the NMDA receptor antagonist ketamine
Celia Morgan,
Psychopharmacology and Addiction Research Centre, University of Exeter, United Kingdom
#156 What is the optimum thiamine dose?
Kylie Dingwall, Principal Research Fellow,
Menzies, NT & Jennifer Delima, Alice Springs Hospital, Alice Springs, NT
#358 Keep it real: A web-based randomised controlled trial for reducing cannabis use & psychotic experiences in young people
Leanne Hides,
Lives Lived Well Group, National Centre for Youth Substance Use Research, School of
Psychology, The University of Queensland, QLD
#361 Fullfix: A pilot trial of a telephone delivered transdiagnostic intervention for comorbid substance and mental health problems in young people
Zoe Walter, Lecturer,
University Of Queensland, QLD
Q&A
Symposium 7
#255 Tobacco use in high priority groups during pregnancy
Rebecca Hyland, The University of Newcastle, School of Medicine and Public Health, NSW; Ratika Kumar, The University of Newcastle, School of Medicine and Public Health, NSW; Gina La Hera Fuentes, The University of Newcastle, School of Medicine and Public Health, NSW; Marilyn Clarke, The University of Newcastle, School of Medicine and Public Health, NSW; Tabassum Rahman, The University of Newcastle, School of Medicine and Public Health, NSW; Gillian Gould, Professor in Health Equity, Southern Cross University, NSW; Melissa Jackson, The University of Newcastle, School of Medicine and Public Health, NSW
Discussant: Kym Yuke, Tobacco Treatment Specialist, Inala Indigenous Health, Southern
Queensland Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health
Care, QLD
10:15 – 10:45
Morning Tea Break
10:45 – 12:20
Morning Plenary -Invited Speakers, APSAD Awards & Poster Highlights
INVITED SPEAKER: Presentation Title TBC
Lisa Marsch, Director, Center for Technology and Behavioral Health (CTBH), Director, Northeast Node of the National Drug Abuse Treatment Clinical Trials Network, United States
APSAD Awards Presentation: Early Career & Mid Career
APSAD EARLY CAREER AWARD WINNER / INVITED SPEAKER: Presentation Title TBC
Speaker To Be Confirmed
Poster Highlights Session 3
#204 randomised, double-blind study investigating the relationship between early childhood trauma and the rewarding effects of morphine
Molly Carlyle, Llw Postdoctoral Research Fellow,
University Of Queensland, QLD
#115 Reasons for Using Electronic Cigarettes in 2016 and 2019 in Australia: A Repeated Cross-sectional Study
Ara Cho, PhD Candidate,
The University Of Queensland, QLD
#131 GHB Withdrawal Admissions in an Australian Residential Detox
Vicky Phan, Addiction Psychiatrist,
Turning Point, VIC
#254 A systematic review of interventions to reduce harms associated with alcohol and other drug use in licensed entertainment settings and outdoor music festivals
Christopher Eassey, PhD Student,
National Drug And Alcohol Research Centre, NSW
#349 Hepatitis C treatment outcomes during the DAA era within a community-based service for people who inject drugs: results for the Queensland Injectors Health Network Treatment and Management Program, 2015-2021
Andrew Smirnov, Senior Lecturer,
The University Of Queensland, QLD
#237 The experiences of participation in the SuperMIX study: A qualitative investigation
Peter Higgs, Associate Professor,
La Trobe University, VIC
#190 Patterns of recreational nitrous oxide use and harms in Australia
Rachel Sutherland, Research Fellow,
NDARC, NSW
#114 Impaired Habit Formation Prevents Adaptive Decision-Making in People with Methamphetamine Use Disorder
Alex Robinson, Doctorate Of Philosophy (Clinical Psychology) Student, Monash University, VIC
#292 Gambling Trends Study: piloting a National Gambling Reporting System
Rebecca Jenkinson
12:20 – 12:50
Lunch Break
12:50 – 14:05
Concurrent Session 6A
Overdose
Concurrent Session 6B
Policy & Legal
Chair: Janni Leung
Concurrent Session 6C
Drug Monitoring
Chair: Darren Roberts
Concurrent Session 6D
SMARTening Recovery
Chair: Pete Kelly
#19 Establishing nurse-led overdose prevention training in public medically-assisted opioid treatment centres: Lessons learned
Louise Durant, Nurse Unit Manager,
Metro North Health, Queensland Health, QLD
#118 The ONE Study (Overdose and take-home Naloxone in Emergency settings): A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with ‘Take Home Naloxone’ supply in Emergency Department settings
Eleanor Black, Addiction Medicine Registrar,
South Eastern Sydney Local Health District Drug & Alcohol Services, NSW
#93 Emergency Department presentations for overdose across nine pharmaceutical opioids
Tina Lam, Research Fellow,
Monash Addiction Research Centre, VIC
#243 Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips
Rachel Sutherland, Research Fellow,
NDARC, NSW
Rapid Fire Presentations – OD & Naloxone
#92 Sustaining naloxone distribution: A rapid review from a pri+B21:E25mary healthcare setting in Kings Cross, Sydney
Rosie Gilliver, Clinical Nurse Consultant,
Kirketon Road Centre, NSW
#151 Opioid overdose and naloxone access among people who recently used opioids or received opioid agonist treatment in Australia: the ETHOS Engage study
Anna Conway, PhD Student,
Kirby Institute, University of New South Wales, NSW
#310 Improving pharmacists’ provision of naloxone through a campaign to normalise the conversation of opioid overdose
Joanna Moullin, Senior Lecturer,
Curtin University, WA
Q&A
#236 Trends in listings and vendors selling drugs on the internet via cryptomarkets: Findings from the Drug and New Technologies (DNeT) project, 2018-2021
Max Pedersen, Research Assistant,
National Drug & Alcohol Research Centre, NSW
#288 The impacts of COVID-19 on illicit drug purchasing and trafficking in Australia
Caitlin Hughes, Matthew Flinders Fellow,
Flinders University, SA
#270 The Next Steps for Drug Law Reform in Australia – Potential and Pitfalls
Anna Olsen, Social Foundations of Medicine,
ANU Medical School, ACT
#14 Challenges and Options in Regulating the Digital Marketing of Alcohol in the Interest of Public Health and Welfare
Robin Room, Professor, Centre For Alcohol Policy Research, La Trobe University, VIC
Food For Thought Presentations
#172 You’ve got mail: drinks are on sale! A study to assess volume and content of direct marketing received from online alcohol retailers in Australia
Stephanie Colbert, PhD Student,
University Of New South Wales, NSW
#134 ACT Inquiry into decriminalisation of illicit drugs – an opportunity to align policy with evidence-based practice
Adam Poulter, Deputy Chief Executive Officer,
ATODA, ACT
#117 Intoxication as Aggravating: An Ethical Analysis
Mary Walker, Lecturer, La Trobe University, VIC
Q&A
Symposium 8
#246 Collaborative multi-agency drug surveillance and response
Thanjira Jiranantakan, Centre for Alcohol and Other Drugs, NSW Ministry of Health, NSW; Jared A. Brown, Manager, Toxicity Surveillance And Response, NSW Ministry Of Health, NSW; Sarah Garland, Biostatistics Trainee, NSW Ministry of Health, NSW; Therese Ryan, Senior Epidemiologist, NSW Ministry of Health, NSW
#257 Tensions arising when designing high-risk drug alerts for health professionals
Isabelle Volpe, Research Officer
RMIT University, VIC & Rita Brien, Turning Point, Eastern Health Clinical School, Monash University, VIC
Q&A
Symposium 9
#28 Future directions for SMART Recovery
Victoria Manning,Monash Addiction Research Centre (MARC), Eastern Health Clinical School, Monash
University, VIC; Alison Beck, School of Psychology, University of Wollongong, NSW; Peter Kelly, School of Psychology, University of Wollongong, NSW; Kristen McCarter, Postdoctoral Researcher,
University Of Newcastle, NSW
Food For Thought Presentations – Treatment
#37 Check Tools: Access insights for ultra-brief interventions for alcohol and drug use
Jeff Buckley, Director, Insight: Centre For AOD Training And Workforce Development, QLD
#60 Towards trauma-informed care when working with alcohol and drug issues
Michelle Taylor, Advanced Clinical Educator,
Insight: Centre for alcohol and other drug training and workforce development, QLD
#53 How can we better support Australians who need help for crystal methamphetamine use?
Steph Kweshaw, Postdoctoral Research Fellow,
University of Sydney, NSW
Q&A
14:05 – 14:30
Break for Poster and On-Demand Content Viewing
14:30 – 15:30
Concurrent Session 7A
Changing Practice
Concurrent Session 7B
Methamphetamines
Concurrent Session 7C
Prescription Opioid Treatment
Chair: Adrian Carter
Concurrent Session 7D
Neurocog Treatment Innovations
Chair: Dan Lubman
Rapid Fire Presentations
#290 What do General Practitioners want from Specialist Alcohol and Other Drugs Services?
Hester Wilson, Doctor, South East Sydney Local Health District, NSW
#36 What do practitioners want to know about in the alcohol and other drug space? Preliminary e-learning package access insights
Jeff Buckley, Director, Insight: Centre For AOD Training And Workforce Development, QLD
#70 Access to primary care services for rural consumers who use methamphetamine
Bernadette Ward, Research staff,
Monash University, VIC
Q&A
#357 Findings of the N-ICE study: A randomised controlled trial of the safety and efficacy of N-acetyl cysteine as a pharmacotherapy for methamphetamine dependence
Rebecca McKetin, National Drug and Alcohol Research Centre, University of New South Wales, NSW
#244 Investigating acute pathology processes in MDMA-related deaths in Australia
Amanda Roxburgh, NHMRC Research Fellow,
Burnet Institute, VIC
#230 Patterns of mental health and alcohol and other drug service use after attending emergency department with an amphetamine-related presentation
Briony Larance, Senior Research Fellow,
University Of Wollongong, NSW
#173 Drug-induced deaths and drug-related hospitalisations by remoteness area of usual residence in Australia, 2018-2019
Nicola Man, Research Fellow, National Drug And Alcohol Research Centre, University of New South Wales, NSW
Q&A
Mini Symposium 3
#41 Prescription Opioid Supply and the Role of Prescription Drug Monitoring Programs: An Overview of Research from the Victorian Implementation
Pallavi Prathivadi, Department of General Practice, Monash University, VIC; Louisa Picco, Monash Addiction Research Centre, Monash University, VIC; Sarah Haines, Turner Institute for Brain and Mental Health, Monash University, VIC
#280 Opioid prescriptions among Australians with chronic non-cancer pain
Ria Hopkins
Rapid Fire & Food For Thought Presentations – OST & Naloxone
#147 Driving and Transport-Related Behaviours and Knowledge of Opioid Agonist Treatment Clients in New South Wales, Australia
Daniel Winter, Research Officer & HDR Candidate,
The University of Sydney, NSW
#186 ‘It can save your life, that’s all I know’: Barriers & facilitators for engagement in take home naloxone for people receiving Opioid Substitution Treatment in regional Australia: an explorative study
Isabella Natalie, Proactive Overdose Response Worker,
Barwon Health, VIC
#15 Case studies of injectable buprenorphine commenced during unplanned inpatient admissions and followed up at a specialist community-based addiction service
Rebecca Brereton, Nurse Practitioner (addiction & Mental Health), Southcity & St Kilda Road Clinic, VIC
Q&A
Symposium 10
#79 Novel neurocognitive training approaches in addictions
Victoria Manning, Monash Addiction Research Centre (MARC), Monash University, VIC; Joshua Garfield, Research Fellow, Monash University, VIC; Hugh Piercy, Monash Addiction Research Centre (MARC), Monash University, VIC; Laura Hughes, School of Psychology, Deakin University, VIC
Rapid Fire Presentations – PIEDS
#266 Using ‘the God of all steroids’ and ‘making a pact with the devil’: The benefits and risks of trenbolone
Mair Uunderwood, Lecturer, The University Of Queensland, QLD
#128 The measured adverse effects of PIEDs use – what is real and what is over-stated? Measured adverse effects data from the PUSH audit
Beng Eu, GP and Co-director, Prahran Market Clinic, VIC
#347 Gamma-hydroxybutyrate Overdose in Inner-Sydney Emergency Departments: a retrospective review
Oliver Harris, Student, University of New South Wales, NSW
Q&A
15:30 – 15:55
Afternoon Tea Break
15:55 – 17:00
Closing Plenary: Late Breaking Presentations: Alcohol & Closing Plenary and Prizes
#338 Replace it – A smartphone app to reduce alcohol consumption: Preliminary findings from a randomised controlled trial
Petra Staiger, Associate Professor, Deakin University, VIC
#324 Health outcomes in misclassified ex-drinkers: Implications for health benefits of moderate consumption
Sarah Callinan, Senior Research Fellow, La Trobe University, VIC
#337 Tackling alcohol’s disease burden using tax and pricing policies
Heng Jiang, Senior Research Fellow, La Trobe University, VIC
#328 How much is alcohol-related absenteeism costing workplaces?
Alice McEntee, Research Fellow, Flinders University, SA
Q&A
Poster and Late Breaker Prizes Presentation
Closing Remarks – President, APSAD
Closing Remarks and Handover – Conference Convenors
Invitation to Attend APSAD 2022 – 2022 Conference Convenor(s)